A Phase 1b, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease
NCT07328451 · RECRUITING · Phase 1
We track 1 ClinicalTrials.gov studies led by Denali Therapeutics Inc. The portfolio skews toward Phase 1 (1 trials).
1 clinical trials sponsored by Denali Therapeutics Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 100% |
Denali Therapeutics Inc currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.
Denali Therapeutics Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Denali Therapeutics Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.